Conditions: Chemotherapy Associated Neutropenia Breast Cancer
Keywords: Filgrastim G-CSF, neutropenia supportive care breast cancer
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 218
Healthy volunteers: no

Brief summary:
The study will assess the efficacy of EP2006 compared to Filgrastim with respect to the mean duration of severe neutropenia during treatment with myelosuppressive chemotherapy in breast cancer patients.

Detailed description:

Arms:
arm 1: Eligible patients will be teated with EP2006 arm 2: Eligible patients will be teated with Filgrastim

Interventions: intervention 1: EP2006 intervention 2: Filgrastim
Intervention descriptions: intervention 1: Eligible patients will be teated with EP2006 intervention 2: Eligible patients will be teated with Filgrastim

Protocol document: